The need for Stroke code and Thrombectomy in Pakistan Authors Hassan Tanvir Ramzi Department of Medicine, Ibne Siena Hospital and Research Institute, Multan, Pakistan Mohammad Shehryar Khurram Department of Neurosurgery, Ibne Siena Hospital and Research Institute, Multan, Pakistan Sana Manzoor Department of Medicine, Ibne Siena Hospital and Research Institute, Multan, Pakistan DOI: https://doi.org/10.47391/JPMA.7037 Abstract Stroke is one of the oldest studied medical illnesses, but it remains the second leading cause of mortality worldwide. The yearly mortality rate is over 5.5 million (1). However, in Pakistan, the estimated annual incidence of stroke is 250/100,000 or 350,000 cases; with the bulk occurring in the middle-aged. Due to a lack of information about the illness and its treatment choices, hundreds of individuals die each year, and an even more significant number live with a lifelong disability (2). If determined to be ischemic, stroke is treated immediately with an intravenous injection of recombinant tissue plasminogen activator, r-tPA, which is the standard gold treatment, according to guidelines, as long as the patients are transferred to a stroke unit within 4.5 hours. Thrombectomy, stents, surgery, and other medicines are also used (1). ---Continue Downloads Full Text Article Published 2022-12-15 How to Cite Hassan Tanvir Ramzi, Khurram , M. S., & Manzoor , S. (2022). The need for Stroke code and Thrombectomy in Pakistan. Journal of the Pakistan Medical Association, 73(1), 212–212. https://doi.org/10.47391/JPMA.7037 More Citation Formats ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver Download Citation Endnote/Zotero/Mendeley (RIS) BibTeX Issue Vol. 73 No. 1 (2023): JANUARY Section LETTER TO THE EDITOR License Copyright (c) 2023 Journal of the Pakistan Medical Association This work is licensed under a Creative Commons Attribution 4.0 International License.